Haemophilia Trial, By Invitation NCT07163260 Sponsor: Novo Nordisk A/S Condition: Haemophilia
Back to Haemophilia

Haemophilia Trial, By Invitation

NCT07163260
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

For experienced doctors treating haemophilia:

  • Haematologists or physicians who specialise in treating haemophilia (in adults or children) and have more than 5 years of experience in this area.
  • People who are able to communicate in English or the language used in their country.
  • People who agree to and sign a consent form before any information is collected.

For patient organisation representatives:

  • People working for an organisation that supports people living with haemophilia, with more than 3 years of experience in that role.
  • People who have an expert-level understanding of haemophilia care and services in their country.
  • People who are able to communicate in English or the language used in their country.
  • People who agree to and sign a consent form before any information is collected.

For patients and caregivers:

  • People of any age who have been diagnosed with haemophilia A or haemophilia B (with or without inhibitors) for more than 2 years.
  • For patients under 18 years old (under 19 in South Korea), a caregiver aged 18 or older (19 or older in South Korea) must sign the consent form on their behalf.
  • People who are able to communicate in English or the language used in their country.
  • People who agree to and sign a consent form before any information is collected.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • Anyone who does not meet one or more of the criteria listed above would not be eligible to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
31 January 2025
Est. completion
19 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇮🇳 India 🇲🇾 Malaysia 🇰🇷 South Korea 🇹🇭 Thailand

Primary endpoints

Estimated prevalence of haemophilia; Estimated incidence of haemophilia; Estimated proportion of patients with haemophilia (PWH) who develop inhibitors (%)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov